Two Sigma Advisers’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68K | Sell |
17,000
-71,400
| -81% | -$286K | ﹤0.01% | 2237 |
|
|
2025
Q1 | $80.4K | Buy |
88,400
+9,700
| +12% | +$8.83K | ﹤0.01% | 2266 |
|
|
2024
Q4 | $218K | Buy |
78,700
+54,400
| +224% | +$151K | ﹤0.01% | 2100 |
|
|
2024
Q3 | $127K | Sell |
24,300
-5,300
| -18% | -$27.7K | ﹤0.01% | 2143 |
|
|
2024
Q2 | $132K | Sell |
29,600
-11,700
| -28% | -$52.2K | ﹤0.01% | 2289 |
|
|
2024
Q1 | $316K | Sell |
41,300
-29,400
| -42% | -$225K | ﹤0.01% | 2051 |
|
|
2023
Q4 | $301K | Sell |
70,700
-25,400
| -26% | -$108K | ﹤0.01% | 2096 |
|
|
2023
Q3 | $404K | Sell |
96,100
-114,900
| -54% | -$483K | ﹤0.01% | 1867 |
|
|
2023
Q2 | $1.18M | Buy |
+211,000
| New | +$1.18M | ﹤0.01% | 1474 |
|